当归内酯联合消渴丸对糖尿病肾病大鼠肾脏保护及血管内皮生长因子信号通路的调节作用

郭杨志 杜娟 姜敏

解剖学报 ›› 2021, Vol. 52 ›› Issue (3) : 439-445.

PDF(10851 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(10851 KB)
解剖学报 ›› 2021, Vol. 52 ›› Issue (3) : 439-445. DOI: 10.16098/j.issn.0529-1356.2021.03.017
组织学胚胎学发育生物学

当归内酯联合消渴丸对糖尿病肾病大鼠肾脏保护及血管内皮生长因子信号通路的调节作用

  • 郭杨志1 杜娟2 姜敏1*
作者信息 +

Effects of angelica lactone combined with Xiaoke pill on regulation of vascular endothelial growth factor signal pathway and on renal protection in diabetic nephropathy rats

  • GUO Yang-zhi DU Juan2  JIANG Min1*
Author information +
文章历史 +

摘要

目的  探讨当归内酯联合消渴丸对糖尿病肾病大鼠血糖调节、肾脏保护及其体内血管内皮生长因子(VEGF)信号通路的调节作用。  方法  75只大鼠随机分为5组,分别为对照组、模型组、消渴丸组、当归内酯组、当归内酯联合消渴丸组,每组15只。除对照组外,其余大鼠建立糖尿病肾病大鼠模型,消渴丸组、当归内酯组、当归内酯联合消渴丸组分别灌胃给予大鼠消渴丸(0.8 g/kg)、当归内酯(20 mg/kg)、消渴丸(0.8 g/kg)联合当归内酯(20 mg/kg),每日给药1次,连续8周后,测定大鼠24 h尿蛋白量、空腹血糖及餐后血糖水平、糖化血清蛋白及糖化血红蛋白水平、空腹胰岛素水平及胰岛素敏感指数、血肌酐(SCr)及血尿素氮(BUN)水平,Real-time PCR检测大鼠胰岛组织胰岛素(INS)及葡萄糖-6-磷酸酶(G6Pase)mRNA水平, HE染色检测大鼠肾脏组织病理学变化,Western blotting及免疫组织化学检测大鼠肾脏VEGF、血管内皮生长因子受体2(VEGFR2)水平。 
  结果  与模型组相比,当归内酯联合消渴丸大鼠24 h尿蛋白量、空腹血糖及餐后血糖水平、糖化血清蛋白及糖化血红蛋白水平、空腹胰岛素水平、SCr及BUN水平、肾脏组织VEGF、VEGFR2蛋白水平及相对积分吸光度均明显降低(P<0.05),胰岛素敏感指数、胰岛组织INS及G6Pase mRNA水平明显升高(P<0.05),差异有统计学意义,同时糖尿病肾病大鼠肾脏组织病理学明显改善。   结论  当归内酯联合消渴丸能够降低糖尿病肾病大鼠血糖水平,同时改善大鼠肾功能及病理变化,其机制可能与调节VEGF信号通路有关。

Abstract

Objective  To investigate the effects of angelica lactone combined with Xiaoke pill on blood glucose regulation, renal protection and vascular endothelial growth factor signal pathway in diabetic nephropathy rats.     Methods  Totally 75 rats were randomly divided into control group, model group, Xiaoke pill group, angelica lactone group and angelica lactone combined with Xiaoke pill group, with 15 rats in each group. Except for the control group, the rest of the rats established diabetic nephropathy model. Rats in Xiaoke pill group, angelica lactone group and angelica lactone combined with Xiaoke pill group were given Xiaoke pill (0.8 g/kg), angelica lactone (20 mg/kg), Xiaoke pill (0.8 g/kg) combined with angelica lactone (20 mg/kg), respectively, once for 8 weeks. The levels of 24-hour urinary protein, fasting and postprandial blood glucose, glycosylated serum albumin and glycosylated hemoglobin, fasting insulin and insulin sensitivity index, serum creatinine (SCr) and urea nitrogen (BUN) were measured. The levels of insulin (INS) and glucose-6-phosphatase (G6Pase) mRNA in islet tissue were measured by Real-time PCR. Renal histopathological changes were detected by HE staining. The levels of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor 2 (VEGFR2) in rat kidney were detected by Western blotting and immunohistochemistry.    Results  Compared with the model group, 24-hour urinary protein, fasting and postprandial blood glucose, glycosylated serum albumin and glycosylated hemoglobin, fasting insulin, SCr and BUN, VEGF and VEGFR2 protein levels and relative integral absorbance of kidney tissue in angelica lactone combined with Xiaoke pill group were significantly lower than those in model group(P<0.05). The insulin sensitivity index, the levels of INS and G6Pase mRNA in islet tissue were significantly increased(P<0.05), and the renal histopathology of diabetic nephropathy rats was significantly improved.    Conclusion  Angelica lactone combined with Xiaoke pill can reduce blood glucose level, increase insulin sensitivity index, and its mechanism may be related to the regulation of VEGF signal pathway.

关键词

当归内酯 / 消渴丸 / 糖尿病肾病 / 血管内皮生长因子信号通路 / 实时定量聚合酶链反应 / 免疫印迹法 / 大鼠

Key words

Angelica lactone / Xiaoke pill / Diabetic nephropathy / Vascular endothelial growth factor signal pathway / Real-time PCR / Western blotting / Rat

引用本文

导出引用
郭杨志 杜娟 姜敏. 当归内酯联合消渴丸对糖尿病肾病大鼠肾脏保护及血管内皮生长因子信号通路的调节作用[J]. 解剖学报. 2021, 52(3): 439-445 https://doi.org/10.16098/j.issn.0529-1356.2021.03.017
GUO Yang-zhi DU Juan JIANG Min. Effects of angelica lactone combined with Xiaoke pill on regulation of vascular endothelial growth factor signal pathway and on renal protection in diabetic nephropathy rats[J]. Acta Anatomica Sinica. 2021, 52(3): 439-445 https://doi.org/10.16098/j.issn.0529-1356.2021.03.017
中图分类号: R285.5    R256.5   

参考文献

[1] Zhang MS, Zhang YN, Xiao D, et al. Highly bioavailable berberine formulation ameliorates diabetic nephropathy through the inhibition of glomerular mesangial matrix expansion and the activation of autophagy[J].Eur J Pharmacol,2020,873:172955.
[2] Kushwaha K, Sharma S, Gupta J. Metabolic memory and diabetic nephropathy: beneficial effects of natural epigenetic modifiers[J].Biochimie,2020,170:140-151.
[3] Kitagawa N, Ushigome E, Tanaka T, et al. Isolated high home systolic blood pressure in patients with type 2 diabetes is a prognostic factor for the development of diabetic nephropathy: KAMOGAWA-HBP study[J].Diabetes Res Clin Pract,2019,158:107920.
[4] Eftekhari A, Vahed SZ, Kavetskyy T, et al. Cell junction proteins: crossing the glomerular filtration barrier in diabetic nephropathy[J].Int J Biol Macromol,2020,148:475-482.
[5] Adelusi TI, Du L, Hao M, et al. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy[J].Biomed Pharmacother,2020,123:109732.
[6] Xu XJ, Chen P, Zheng QL, et al. Effect of pioglitazone on diabetic nephropathy and expression of HIF-1α and VEGF in the renal tissues of type 2 diabetic rats[J].Diabetes Res Clin Pract,2011,93(1):63-69.
[7] Wang DQ, Miao XJ, Gao J, et al. The 150-kDa oxygen-regulated protein (ORP150) regulates proteinuria in diabetic nephropathy via mediating VEGF[J].Exp Mol Pathol,2019,110:104255.
[8] Tufro A, Veron D. VEGF and podocytes in diabetic nephropathy[J].Semin Nephrol,2012,32(4):385-393.
[9] Song Y, Xia H, Li Q, et al. Expression of VEGF and VEGFA in type 2 diabetic nephropathy and changes after treatment[J]. Journal of Hunan Normal University(Medical Sciences Edition) ,2017,14(1):15-18.  (in Chinese)
宋怡, 夏骅,李青,等.2型糖尿病肾病VEGF与VEGF-A的表达及治疗后的变化[J].湖南师范大学学报(医学版),2017,14(1):15-18. 
[10] Mao LM, Zhu B, Fu JJ, et al. Serum ADPN and VEGF levels in patients with stage IV diabetic nephropathy and their correlation with urine protein and eGFR[J]. Chinese Journal of Integrated Traditional and Western Nephrology,2018,19(12):1064-1067.  (in Chinese)
毛黎明,朱斌,富佳杰,等.糖尿病肾病Ⅳ期患者血清ADPN、VEGF的水平及其与尿蛋白、eGFR的相关性分析[J].中国中西医结合肾病杂志,2018,19(12):1064-1067. 
[11] Wang GF, Cui YL, Li N, et al. Effect of ligustrazine on the expression of GSK-3β, VEGF and ICAM-1 in renal tissues of diabetic nephropathy rats[J]. Journal of Clinical and Experimental Medicine,2019,18(22):2366-2369.  (in Chinese)
王国峰,崔玉玲,李宁,等.川芎嗪对糖尿病肾病大鼠肾组织GSK-3β、VEGF和ICAM-1表达的影响[J].临床和实验医学杂志,2019,18(22):2366-2369. 
[12] Wu YD, Yuan XK, Li DY, et al. The effect of quinsulfacyclohexanone on diabetic nephropathy in rats and its effect on the expression of AngⅡ and VEGF in kidney[J]. Chinese Journal of Comparative Medicine,2019,29(10):98-104.  (in Chinese)
吴运斗,袁新科,李大勇,等.喹磺环己酮对大鼠糖尿病肾病的作用及对肾脏AngⅡ、VEGF表达的影响[J].中国比较医学杂志,2019,29(10):98-104. 
[13] Li ZF, Li YF, Hui YCh, et al. Preliminary study on the antioxidant effect of the components of Xiaoke pills[J]. Chinese Journal for Clinicians, 2011,39(10):53-54.  (in Chinese)
李子凤, 李玉凤, 回园勅, 等.消渴丸组分的抗氧化作用初探[J].中国临床医生,2011,39(10):53-54. 
[14] Li LX. Application of Xiaoke pills in the treatment of diabetes[J]. Modern Diagnosis and Treatment,2014,(16):3666-3667.  (in Chinese)
李乐项.消渴丸在治疗糖尿病中的应用[J].现代诊断与治疗,2014,(16):3666-3667. 
[15] Zhang HCh. Xiaoke pills in treating 60 patients with type 2 diabetes[J]. China Pharmaceuticals,2015,(22):171-172.  (in Chinese)
张海超.消渴丸治疗2型糖尿病患者60例[J].中国药业,2015,(22):171-172. 
[16] Liu Y. Effect of Xiaoke pills on blood pressure and polyuria in type 2 diabetes[J]. Shanxi Journal of Traditional Chinese Medicine,2016,37(9):1145-1147.  (in Chinese)
刘亚.消渴丸对2型糖尿病血压及多尿的影响[J].陕西中医,2016,37(9):1145-1147. 
[17] Thanusha TK ,Deepake S, Utpal D. α-Angelica lactone in a new role: facile Access to N-Aryl tetrahydroisoquinolinones and isoindolinones via organocatalytic α-CH2 oxygenation[J].Org Lett, 2019,21(8):2532-2535.
[18] Griswold JA, Horwitz MA, Leiva LV, et al. Correction to “diastereoselective organocatalytic addition of α-angelica lactone to β-halo-α-ketoesters”[J]. J Org Chem,2017,82(7): 4006.
[19] Peng M, Zhang YW. Adjuvant treatment of Danggui Buxue Decoction on diabetic nephropathy[J]. Hebei Journal of Traditional Chinese Medicine,2016,38(11):1702-1705. (in Chinese)
彭敏,张莹雯.当归补血汤对糖尿病肾病的辅助治疗作用[J].河北中医,2016,38(11):1702-1705. 
[20] Zhang QT, Hou MN, Peng XJ, et al. Study on the mechanism of action of Danggui Buxue Decoction based on integrated pharmacology in preventing and treating diabetes[J]. Chinese Pharmacological Bulletin,2019,35(9):1314-1319.  (in Chinese)
张倩韬,侯敏娜,彭修娟,等.基于整合药理学的经典名方当归补血汤防治糖尿病的作用机制研究[J].中国药理学通报,2019,35(9):1314-1319. 
[21] Rao JY, Wei SCh, Wang XK, et al. The effect and mechanism of guava leaf total triterpenes on renal injury in diabetic nephropathy rats[J]. Chinese Journal of Clinical Pharmacology,2019,35(15):1617-1620.  (in Chinese)
饶姣雨,魏崧丞,王小康,等.番石榴叶总三萜对糖尿病肾病大鼠肾损伤的改善作用及机制研究[J].中国临床药理学杂志,2019,35(15):1617-1620. 
[22] Sun MD, Tian H, Yu Y, et al. Berberine regulates the expression of aquaporin-1 through PI3K/Akt pathway to improve renal function in diabetic rats[J]. Chinese Journal of Anatomy,2019,42(6):561-564.  (in Chinese)
孙明东,田鹤,于洋,等.小檗碱通过PI3K/Akt通路调控水通道蛋白-1表达改善糖尿病大鼠肾功能[J].解剖学杂志,2019,42(06):561-564. 
[23] Tao M, Yuan ChH, Bao Y, et al. Comparison and improvement of isolation and purification methods for rat islets[J]. Laboratory Animal Science,2012,29(5):19-23.  (in Chinese)
陶明,原春辉,鲍杨,等. 大鼠胰岛分离和纯化方法的比较及改进[J]. 实验动物科学,2012,29(5):19-23. 

基金

国家自然科学基金青年科学基金项目

PDF(10851 KB)

Accesses

Citation

Detail

段落导航
相关文章

/